Previous Next

BLOOD COMPONENT THERAPY

A major advance in the field of blood banking has been the development of blood component therapy. It is beyond the scope of this chapter to describe the various separation steps in detail, but a superficial outline of the scheme by which various blood components are derived is shown in Figure 47-10 . The basic philosophy is based on the concept that patients are best treated by administration of the specific fraction of blood that they lack. This concept has presented problems to the surgical team, who often desire whole blood.

Packed Red Blood Cells

PRBCs contain the same amount of hemoglobin as whole blood, but much of the plasma has been removed. The hematocrit value is 40% in whole blood and 70% in packed erythrocytes ( Table 47-15 ). The position of the American Association of Blood Banks has been that transfusion of whole blood is required primarily for blood loss acute enough to cause hypovolemic shock. More specifically, they state that the primary indication for whole blood is for patients who are actively bleeding and have sustained a loss of greater than 25% of their total blood volume. In other words, whole blood provides oxygen-carrying capacity and intravascular blood volume expansion. Less severe degrees of hemorrhage may be effectively treated with PRBCs, retaining the plasma and the


1822

TABLE 47-15 -- Comparison of whole blood and packed red blood cells
Value Whole Blood Packed Red Blood Cells
Volume (mL) 517 300
Erythrocyte mass (mL) 200 200
Hematocrit (%) 40 70
Albumin (g) 12.5 4
Globulin (g) 6.25 2
Total protein (g) 48.8 36
Plasma sodium (mEq) 45 15
Plasma potassium (mEq) 15 4
Plasma acid (citric-lactic) (mEq) 80 25
Donor-to-recipient ratio 1 unit per patient 1 unit per 4–6 patients
From Landers DF, Hill GE, Wong KC, et al: Blood transfusion-induced immunomodulation. Anesth Analg 82:187, 1996.

components thereof for other patients (see Fig. 47-10 ). Many blood banks have religiously followed this principle, and whole blood cannot be obtained in the operating rooms except by special request. In essence, blood bankers are saying that except for a rare situation (e.g., hypovolemic shock), whole blood is not necessary.

Because of this trend, some hospitals do not have whole blood readily available. This may force the surgical team to use PRBCs for losses of blood more than 1000 to 1500 mL/70 kg. One fear has been that if large volumes of PRBCs reconstituted with a crystalloid are given, serum albumin deficiencies may result. However, administration of saline-reconstituted RBCs for losses of blood less than 2500 mL/70 kg usually does not induce low serum levels of albumin, although fibrinogen concentration can be decreased in the recipient.

The administration of PRBCs is facilitated by reconstituting them with a crystalloid or colloid; however, not all crystalloids are suitable. If the solution contains calcium, clotting occurs. Lactated Ringer's solution is usually not recommended for use as a diluent for PRBCs ( Table 47-16 ). Conversely, using flow rates and clot formation, Cull and colleagues [134] found lactated Ringer's solution and normal saline to be equally acceptable. A more important factor may be whether the diluent is hypotonic with respect to plasma. If so, the RBCs will swell and eventually lyse. Solutions that cause hemolysis are listed in Table 47-16 . Clinicians who fear that the crystalloid-reconstituted RBCs may cause low serum concentrations may be tempted to use a plasma derivative, such as Plasmanate.[135] However, these solutions also can cause hemolysis. The osmolality of Plasmanate is only 180 mOsm/kg. Solutions recommended for reconstituted packed erythrocytes are 5% dextrose in 0.4% saline, 5% dextrose in 0.9% saline, 0.9% saline, and Normosol-R with a pH of 7.4.

Previous Next